Addressing Disparities and Variations in Care in GU Oncology

CME Available: auau.auanet.org/node/37337

Host: Jay D. Raman, MD, FACS

Guests: Kelvin Moses, MD, PhD and Svetlana Avulova, MD

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

1. Discuss the impact of race and cultural barriers on optimal GU cancer care.

2. Evaluate financial toxicity as a barrier to optimal patient care in urologic cancer.

3. Incorporate culturally sensitive communications to ensure quality care and reduce biases across diverse patient populations.

ACKNOWLEDGEMENTS:

This series is supported by independent educational grants from:

Astellas

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Lantheus Medical Imaging

Merck & Co., Inc.

Pfizer, Inc.

Sanofi Genzyme